Roivant has its own TYK2/JAK1 inhibitor in development in the form of brepocitinib, which the biopharma licensed from Pfizer ...

Skin symptoms may clear with biologics in psoriasis, but hidden internal inflammation often persists, contributing to major ...

A new study reveals psoriasis may increase the risk of obesity and fatty liver despite skin improvements Learn why managing inflammation beyond the skin is essential ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

Residual inflammation persisted among patients with psoriasis despite optimal disease response to biologic therapies, putting ...

How does one live with psoriasis? From medication to nutrition (and beyond), Olivia Marks goes in search of clear answers.

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, ...

Learn to distinguish between nail psoriasis and nail fungus through key visual differences, associated symptoms, and ...

The dosing interval for ixekizumab may be extended in some patients with plaque psoriasis, and switching between biologics ...

Psoriasis, with its systemic inflammatory nature and high risk of cardiovascular disease, could provide a valuable framework ...

Do not make the mistake of considering psoriasis as dandruff. It is important to know the difference between scalp psoriasis ...